NOVEL CRYSTALS OF HYDROXAMIC ACID DERIVATIVE, PRODUCTION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION
申请人:FUJIFILM Toyama Chemical Co., Ltd.
公开号:US20200308103A1
公开(公告)日:2020-10-01
Crystals of (2S)-2-((4-((4-((1S)-1,2-dihydroxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-N-hydroxy-N′,2-dimethylmalonamide having diffraction peaks at diffraction angles (2θ) of 3.8±0.2°, 7.7±0.2°, and 10.8±0.2°, etc., or 8.2±0.2°, 12.4±0.2°, and 13.3±0.2°, etc., in powder X-ray diffraction, a production method thereof, and a pharmaceutical composition.
(2S)-2-((4-((4-((1S)-1,2-dihydroxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-N-hydroxy-N′,2-dimethylmalonamide的晶体在粉末X射线衍射中具有衍射角(2θ)为3.8±0.2°、7.7±0.2°和10.8±0.2°等,或者8.2±0.2°、12.4±0.2°和13.3±0.2°等。该晶体的制备方法和药物组合物。